Table 1.
Nested MANOVA and post-hoc F-tests on endocrine parameters.
F | p | |
---|---|---|
AROM mRNA in rostral hypothalamus | ||
SDF vs. VAF | 0.83 | 0.37 |
M vs. F | 5.61 | 0.021* |
AR mRNA in rostral hypothalamus | ||
SDF vs. VAF | 1.59 | 0.21 |
M vs. F | 0.76 | 0.39 |
LH-R mRNA in gonad | ||
SDF vs. VAF | 0.022 | 0.88 |
M vs. F | 11.46 | 0.0012* |
Testosterone, pre-GnRH challenge | ||
SDF vs. VAF | 1.45 | 0.23 |
M vs. F | 211.27 | <.0001* |
Testosterone, post-GnRH challenge | ||
SDF vs. VAF | 0.55 | 0.46 |
M vs. F | 888.14 | <.0001* |
Testosterone, pre-LH challenge | ||
SDF vs. VAF | 0.54 | 0.46 |
M vs. F | 141.43 | <.0001* |
Testosterone, post-LH challenge | ||
SDF vs. VAF | 0.10 | 0.75 |
M vs. F | 841.80 | <.0001* |
LH, pre-GnRH challenge | ||
SDF vs. VAF | 0.026 | 0.87 |
M vs. F | 0.14 | 0.71 |
LH, post-GnRH challenge | ||
SDF vs. VAF | 0.03 | 0.85 |
M vs. F | 8.04 | 0.0061* |
F = Female, M = Male, SD = South Dakota, VA = Virginia. Significant results (p < 0.05) denoted with asterisk.